News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Friday, March 24, 2017

Top Breaking News

News from Around the Web
Why Merck & Co. (MRK)'s $95 Million Bet on cCAM Biotherapeutics in 2015 Did Not Pay Off
Embattled Valeant (VRX)'s New CEO Took Home $62.7 Million Last Year
Redx Pharma Cuts 86 Jobs As Group Shifts Focus
Merck & Co. (MRK) Is Dangerously Close To A Breakdown
Valeant (VRX): Damaged Goods Or A Deeply Discounted Drug Company?
Old Blood Can Be Made Young Again, University of Ulm Scientists Reveal
The Science Of Sex's 'Afterglow', Psychological Science, Study Reveals
Smartphone Can Accurately Test Sperm Count, Massachusetts General Hospital Study
This Super-Cheap Camera Will Take The Sting Out Of Those Eye Exams, University of Illinois Study Reveals
Researchers Make Flexible Glass For Tiny Medical Devices, Brigham Young University Study
Lexington Medical CEO Hopes State Loan Will Help Create 65 New Jobs
X-Ray Machine Maker Smiths Group's New Strategy Works as Profit More Than Doubles

Press Releases
EMD Serono Release: FDA Grants Approval For BAVENCIO (Avelumab), The First Immunotherapy Approved For Metastatic Merkel Cell Carcinoma
FDA Bestows Breakthrough Tag on Genentech (RHHBY)'s Rituxan for Pemphigus Vulgaris
New Coalition Formed To Save NIH Funding
European Commission (EC) Approves Amgevita (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
Xenon Pharmaceuticals Inc. Announces XEN801 Did Not Meet Efficacy Endpoints In Phase 2 Clinical Trial In Patients With Moderate To Severe Acne
Bristol-Myers Squibb (BMY) Receives Positive CHMP Opinion Recommending Opdivo (Nivolumab) For The Treatment Of Squamous Cell Cancer Of The Head And Neck In Adults Progressing On Or After Platinum-Based Therapy
Data From Phase II Study Of Progenics (PGNX)’ PSMA-Targeted Imaging Agent 1404 Published In Journal Of Nuclear Medicine
Shionogi Release: FDA Approves Symproic (Naldemedine) Once-Daily Tablets C-II For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-Cancer Pain
Janssen-Cilag International NV (JNJ) Release: EPREX (Epoetin Alfa) Marketing Authorization Extended To Include Treatment Of Symptomatic Anaemia In Patients With Low Or Intermediate-1-Risk Myelodysplastic Syndromes
Almirall And Sun Pharma (SUNPHARMA.NS) Announce Regulatory Filing Of Tildrakizumab In Europe
Regen BioPharma Provides Update On NR2F6 Small Molecule Optimization Program For Treating Cancer And Arthritis
Atossa Genetics (ATOS) Opens Enrollment In Study Of Endoxifen
Pfizer (PFE) Receives Positive CHMP Opinion For TRUMENBA For Prevention Of Meningococcal Group B Disease
EMA’s CHMP Recommends Approval Of Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma
Sihuan Pharmaceutical Acquires Ambest Pharma China For $160 Million
ShangPharma Plans To Merge CRO/CMO Operations With Public Entity
C4 Therapeutics And Calico Enter Strategic Partnership To Discover Novel Therapeutics Based On Targeted Protein Degradation Has Identified KANSARL Fusion Gene As The First Familially-Inherited Cancer Fusion Gene Specific To The Population Of European Ancestry Origin
LaVoieHealthScience Announces New PR Clients To Its Roster
Ignyta (RXDX) Announces Exploration Of Strategic Options For Taladegib, Enabled By Amendment Of Taladegib License Agreement With Eli Lilly (LLY)
PureTech Announces Licensing And Equity Agreement With Novartis AG (NVS) To Advance Clinical Stage mTORC1 Programs
Argentum Persists In Challenging The "Evergreening" Patent On UCB, Inc. (UCBJF.PK)'s VIMPAT
Mount Tam Biotechnologies Announces That The Japan Patent Office Has Allowed A Key Patent For Lead Compound TAM-01
C-Bridge Capital And Tasly Invest $150 Million In Two China Biopharmas
GlobeImmune (GBIM) Announces Majority Stock Sale
Bellicum (BLCM) Announces Pricing Of Public Offering Of Common Stock
GlobeImmune (GBIM) Announces Majority Stock Sale
Avid Bioservices, Inc. Receives Mutliple 2017 CMO Leadership Awards For Quality, Reliability, Capabilties, Expertise And Compatibility
Pressure BioSciences, Inc. (BBII) Significantly Expands Marketing And Sales Capabilities
BioPharmX Reports Fourth Quarter And Full Year 2017 Financial Results
Dicerna (DRNA) To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call On March 30, 2017
Eleven Bio (EBIO) Reports Fourth Quarter And Full Year 2016 Financial Results
Galapagos (GLPG.BR) Release: Publication Of The Annual Report And Invitation To The Annual And Extraordinary Shareholders' Meetings
NovaBay (NBY) Reports 2016 Full Year And Fourth Quarter Financial Results And Provides 2017 Financial Guidance
Verastem (VSTM) Reports Year-End 2016 Financial Results
Hutchison China MediTech (Chi-Med) Appoints Dr Weiguo Su, Chief Scientific Officer, To Board Of Directors
Woody Sherman Ph.D, Joins Silicon Therapeutics As CSO, Leading Efforts On Platform Development And Drug Design
Richard Peterson Joins Sienna Biopharma As Chief Financial Officer
Reata Pharmaceuticals, Inc. Appoints David Chapman< As Vice President, Marketing
Ultivue Announces Expansion Of Executive Team
Arbutus Biopharma (ABUS) Announces Appointment Of Daniel Burgess To Board Of Directors
City of Hope’s Linda Malkas, Ph.D., Appointed To State’s Stem Cell Agency Board
Eleven Bio (EBIO) Reports Fourth Quarter And Full Year 2016 Financial Results
John A. Orwin Joins Retrophin (RTRX) Board Of Directors
Smartphone Can Accurately Test Sperm Count, Massachusetts General Hospital Study
This Super-Cheap Camera Will Take The Sting Out Of Those Eye Exams, University of Illinois Study Reveals
Researchers Make Flexible Glass For Tiny Medical Devices, Brigham Young University Study
Sonion Brings in a New CEO, Effective April 1
Genomic Health (GHDX) Release: Published Outcomes Results From SEER Registries Indicates That Many Node-Positive Breast Cancer Patients Can Avoid Chemotherapy Based On Oncotype DX Results
Oxford Immunotec (OXFD) Announces Release Of New National Tuberculosis Test Data And Screening Grant For High Risk Patients On World TB Day
Blue Earth Diagnostics Receives Positive CHMP Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer
Medtronic (MDT) Release: New Guidelines Support Use Of Cardiac Monitoring For Patients With Unexplained Fainting
FDA Licenses Eight New Quotient Limited (QTNTU) Reagent Products For Sale In The U.S.
Endonovo Files A New Patent Application On Method To Treat Tissues And Organs Using Its Non-Invasive Electroceutical Technology
Perthera Adds Germline Testing To Its Precision Cancer Analysis (PCA) For Cancer Patients
Praesidian Capital Exits Successful $23 Million Investment In PromptCare Companies
Syneron Medical (ELOS) Announces Availability Of Its Annual Report On Form 20-F Through Its Website
Company Profile For Fabric Genomics
SeraCare Life Sciences (SRLS) Announces Launch Of Industry's First Multiplexed Inherited Cancer Reference Material
DexCom (DXCM) Release: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM For All People With Diabetes On Intensive Insulin Therapy
Acuamark Diagnostics Announces Addition Of Dr. Michael Hanbury To Its Board Of Directors
Neovasc (NVC) Announces Results For The Fourth Quarter And Fiscal Year 2016
Alphatec Holdings Completes Its Senior Leadership Team With Appointment Of Brian Snider, Executive Vice President, Strategic Marketing And Product Development
Owlstone Medical Wins Business Innovation Award For Breath Biopsy Technology
BBI Solutions & Dr C. Sturgeon Consider International Standards For Cancer Biomarkers